The popularity of Viagra initially fueled a surge for pharma, however recent shifts present a uncertain outlook for investors. Off-patent alternatives are eating into earnings, and persistent litigation add additional https://lewisqsjq616872.blogocial.com/sildenafil-and-big-pharma-a-volatile-bet-77206229